HK1204559A1 - 包含氨基羧酸鹽的固體組合物 - Google Patents
包含氨基羧酸鹽的固體組合物Info
- Publication number
- HK1204559A1 HK1204559A1 HK15105091.0A HK15105091A HK1204559A1 HK 1204559 A1 HK1204559 A1 HK 1204559A1 HK 15105091 A HK15105091 A HK 15105091A HK 1204559 A1 HK1204559 A1 HK 1204559A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- solid composition
- carboxylate salt
- amino carboxylate
- amino
- salt
- Prior art date
Links
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 title 1
- 239000008247 solid mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013079006 | 2013-04-04 | ||
| PCT/JP2014/059812 WO2014163132A1 (ja) | 2013-04-04 | 2014-04-03 | アミノカルボン酸の塩の固形組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1204559A1 true HK1204559A1 (zh) | 2015-11-27 |
Family
ID=51658423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15105091.0A HK1204559A1 (zh) | 2013-04-04 | 2015-05-28 | 包含氨基羧酸鹽的固體組合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9675570B2 (zh) |
| EP (1) | EP2826477B1 (zh) |
| JP (1) | JP5627062B1 (zh) |
| KR (1) | KR102142257B1 (zh) |
| CN (1) | CN104334169B (zh) |
| BR (1) | BR112014029538B1 (zh) |
| CA (1) | CA2870675C (zh) |
| ES (1) | ES2638420T3 (zh) |
| HK (1) | HK1204559A1 (zh) |
| IN (1) | IN2014MN02116A (zh) |
| TW (1) | TWI645863B (zh) |
| WO (1) | WO2014163132A1 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017019920B1 (pt) * | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica |
| US10561628B2 (en) | 2015-03-19 | 2020-02-18 | Daiichi Sankyo Company, Limited | Solid preparation including antioxidant |
| FR3075662B1 (fr) * | 2017-12-21 | 2022-06-24 | Ifp Energies Now | Procede de pretraitement pour ameliorer le remplissage d'une enceinte avec des particules solides |
| TWI845532B (zh) | 2018-07-30 | 2024-06-21 | 日商第一三共股份有限公司 | 含安定劑之醫藥品的固體製劑 |
| US20230081350A1 (en) | 2019-12-23 | 2023-03-16 | Daiichi Sankyo Company, Limited | Film-coated tablets having smooth surface |
| TW202220643A (zh) | 2020-07-27 | 2022-06-01 | 日商第一三共股份有限公司 | 含有米羅巴林苯磺酸鹽之口腔內崩散錠 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3928183A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
| JPH11189547A (ja) * | 1997-12-26 | 1999-07-13 | Taisho Pharmaceut Co Ltd | 安定化されたニコランジル製剤及びその製造方法 |
| JP2001064177A (ja) * | 1999-08-16 | 2001-03-13 | Schering Ag | ベンズアミド誘導体を有効成分とする製剤 |
| WO2006056874A1 (en) | 2004-11-25 | 2006-06-01 | Pfizer Limited | Salt form |
| GB0425955D0 (en) * | 2004-11-25 | 2004-12-29 | Pfizer Ltd | Salt form |
| JP4691434B2 (ja) * | 2005-11-08 | 2011-06-01 | 東和薬品株式会社 | 安定化されたカベルゴリン固形製剤 |
| MX2010003394A (es) * | 2007-09-28 | 2010-04-09 | Daiichi Sankyo Co Ltd | Derivado de gamma-aminoacido biciclico. |
| JP5650532B2 (ja) * | 2008-08-18 | 2015-01-07 | 三菱商事フードテック株式会社 | 新規マンニトール打錠用賦形剤 |
| JP2010241796A (ja) * | 2009-03-17 | 2010-10-28 | Daiichi Sankyo Co Ltd | 二環性γ−アミノ酸誘導体含有医薬組成物 |
| ES2635354T3 (es) * | 2009-03-26 | 2017-10-03 | Daiichi Sankyo Company, Limited | Procedimiento de producción de un derivado de ácido gamma-amino bicíclico |
| JP5674666B2 (ja) * | 2009-08-11 | 2015-02-25 | 富士化学工業株式会社 | 崩壊性粒子組成物及び口腔内速崩壊錠 |
-
2014
- 2014-04-03 CN CN201480001374.3A patent/CN104334169B/zh active Active
- 2014-04-03 EP EP14779687.4A patent/EP2826477B1/en active Active
- 2014-04-03 IN IN2116MUN2014 patent/IN2014MN02116A/en unknown
- 2014-04-03 KR KR1020147032839A patent/KR102142257B1/ko active IP Right Grant
- 2014-04-03 TW TW103112494A patent/TWI645863B/zh active
- 2014-04-03 CA CA2870675A patent/CA2870675C/en active Active
- 2014-04-03 BR BR112014029538-7A patent/BR112014029538B1/pt active IP Right Grant
- 2014-04-03 WO PCT/JP2014/059812 patent/WO2014163132A1/ja active Application Filing
- 2014-04-03 JP JP2014532752A patent/JP5627062B1/ja active Active
- 2014-04-03 ES ES14779687.4T patent/ES2638420T3/es active Active
- 2014-11-25 US US14/553,341 patent/US9675570B2/en active Active
-
2015
- 2015-05-28 HK HK15105091.0A patent/HK1204559A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2870675A1 (en) | 2014-10-09 |
| EP2826477B1 (en) | 2017-05-31 |
| US9675570B2 (en) | 2017-06-13 |
| JPWO2014163132A1 (ja) | 2017-02-16 |
| TWI645863B (zh) | 2019-01-01 |
| CN104334169B (zh) | 2016-11-02 |
| BR112014029538A2 (pt) | 2017-06-27 |
| KR20150138800A (ko) | 2015-12-10 |
| CN104334169A (zh) | 2015-02-04 |
| US20150079166A1 (en) | 2015-03-19 |
| BR112014029538B1 (pt) | 2022-07-05 |
| EP2826477A1 (en) | 2015-01-21 |
| EP2826477A4 (en) | 2015-09-09 |
| JP5627062B1 (ja) | 2014-11-19 |
| KR102142257B1 (ko) | 2020-08-07 |
| ES2638420T3 (es) | 2017-10-20 |
| WO2014163132A1 (ja) | 2014-10-09 |
| TW201517932A (zh) | 2015-05-16 |
| IN2014MN02116A (zh) | 2015-09-04 |
| CA2870675C (en) | 2017-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1245769B (zh) | 作為jak抑制劑的聯吡唑鹽 | |
| SI3043785T1 (sl) | Uporaba R-ketamina in njegove soli kot farmacevtska sredstva | |
| ME03465B (me) | Farmaceutska kompozicija s-ketamin hidrohlorida | |
| HK1225372A1 (zh) | 氨基酸衍生物 | |
| HK1214255A1 (zh) | -醯基氨基噻唑衍生物或其鹽 | |
| HK1204559A1 (zh) | 包含氨基羧酸鹽的固體組合物 | |
| IL243829A0 (en) | Production method for saline preparation | |
| GB201208293D0 (en) | Hydrochlorice salt of peptide | |
| HK1248224A1 (zh) | 作為阿片激動劑的α-6-MPEG6-O-羥基可酮的固體鹽形式以及其用途 | |
| HRP20182110T1 (hr) | Sastav spojeva tiakumicina | |
| HK1204865A1 (zh) | 消滅棘手的有害動物的組合物 | |
| IL245452B (en) | Salts of Armachol |